Bioanalysis and DMPK

Build stronger foundations with bioanalytical solutions for drug metabolism and pharmacokinetics (DMPK) applications.

Overview

Enhance your bioanalysis and DMPK workflows while simplifying method development and reducing training needs. Liquid chromatography and mass spectrometry (LC-MS) solutions from SCIEX—including our software and trusted services and support—are intuitive, robust and sensitive.

Accurately identify and monitor biomarkers, active pharmaceutical ingredients (APIs) and metabolites on a single software platform. 

Bioanalysis and DMPK applications

Take control of both routine and complex ADME and DMPK studies with robust solutions for the comprehensive characterization of drug candidates.

ADME-Tox and DMPK

Advance the development of your next therapeutic drug with easy-to-operate, integrated analytical systems that can provide new insights into ADME-Tox and DMPK. Rapidly and comprehensively characterize drug candidates with robust and sensitive solutions for identification, monitoring and quantitation.

Learn more
Biomarker quantitation

Explore the potential of trusted LC-MS/MS solutions designed to simplify and accelerate biomarker quantitation. Bring drug candidates through the development pipeline more efficiently and confidently with accurate results obtained using innovative hardware and software, lab-tested methods and expert support.

Learn more
Metabolite identification

Advance your drug discoveries with reliable metabolite data that save time and money. Our range of solutions supports routine monitoring and complex identification to give your team confidence during synthetic therapeutic development.

Learn more
Quantitative bioanalysis

Unlock reliable and sensitive quantitative biological data with LC-MS solutions that work as hard as you do. Make your bioanalysis effortless when quantifying small and large molecule therapeutic candidates, including cyclic peptides and glucagon-like peptide-1 (GLP-1).

Learn more

Testimonial

“As Veloxity Labs has grown, so has the complexity of the projects our sponsors bring to us, including peptides, proteins, challenging matrices, lower requested LLOQ, and accelerated timelines. The recent addition of the ZenoTOF 8600 system represents another innovative tool for how we approach bioanalytical workflows.

From a technical perspective, the ZenoTOF 8600 system opens new opportunities for high-resolution and improved selectivity workflows that complement our existing triple quadrupole platforms. We’re seeing clear advantages in peptide and complex analyte method development, where selectivity gains accelerate method development and obtain better LLOQ in our experience.

Our relationship with the SCIEX team has been a true collaboration. SCIEX continues to lead the industry in delivering sensitive, rugged mass spectrometers for bioanalysis, and the ZenoTOF 8600 system strengthens Veloxity Labs’s ability to say ‘yes’ to more complex programs and deliver results faster. That’s exactly what our clients expect from us, and it’s why collaborations like this one with SCIEX matter.”

Shane Needham, PhD
Veloxity Labs, Co-Founder, President, and CEO

Let's connect

Stay up-to-date with conversations on LinkedIn